NYSE: GGenpact Ltd Stock
$39.13+0.17 (+0.44%)
Updated Oct 14, 2024
G Price
$39.13
Fair Value Price
N/A
Market Cap
$6.97B
52 Week Low
$29.41
52 Week High
$39.95
P/E
10.93x
P/B
2.98x
P/S
1.26x
PEG
N/A
Dividend Yield
1.52%
Revenue
$4.59B
Earnings
$647.84M
Gross Margin
35.4%
Operating Margin
14.86%
Profit Margin
14.1%
Debt to Equity
1.22
Operating Cash Flow
$537M
Beta
0.98
Next Earnings
Nov 4, 2024
Ex-Dividend
N/A
Next Dividend
N/A
G Overview
Genpact Limited offers business process management services including aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Its clients are in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact operates but generates most of its revenue in India. Genpact was founded in 1997 and is headquartered in New York City, NY.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how G scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
G is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
G is good value based on its earnings relative to its share price (10.93x), compared to the US market average (27.44x)
P/E vs Market Valuation
G is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more G due diligence checks available for Premium users.
Be the first to know about important G news, forecast changes, insider trades & much more!
G News
Valuation
G price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.93x
Industry
29.72x
Market
27.44x
G is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
G is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
G price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.98x
Industry
5.51x
G is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
G's financial health
Profit margin
Revenue
$1.2B
Net Income
$122.0M
Profit Margin
10.4%
G's Earnings (EBIT) of $682.11M... subscribe to Premium to read more.
Interest Coverage Financials
G's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2B
Liabilities
$2.8B
Debt to equity
1.22
G's short-term assets ($2.27B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
G's short-term assets ($2.27B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
G's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
G's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$209.3M
Investing
-$19.7M
Financing
$250.5M
G's operating cash flow ($537.14M)... subscribe to Premium to read more.
Debt Coverage Financials
G vs Information Technology Service Stocks
Genpact Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.